C&R Research Inc. (KOSDAQ: A359090)
Health Care · Life Sciences Tools & Services · KR
₩2,325.00
+1.97% today · -51.5% 1Y
C&R Research Inc. (KOSDAQ: A359090) operates in the Life Sciences Tools & Services industry within the Health Care sector. The company is valued at $19.88M.
Over the last twelve months the share price has lost 51.5%, trading between 1.67K and 5.89K.
Tweenvest scores C&R Research Inc. across four factors: quality 73/100, value 66/100, dividend 28/100. Its strongest factor is quality.
A359090 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $19.88M
- Revenue (TTM)
- $41.04M
- P/E
- 16.16
- EPS
- 143.88
- Dividend yield
- 2.15%
- Beta (5Y)
- 0.01
- 52-week high
- ₩5,890.00
- 52-week low
- ₩1,667.00
- Avg volume (3M)
- —
- Shares outstanding
- 11.49M
- Employees
- —
- Next earnings
- —
Other Life Sciences Tools & Services companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| HyEnergy S.A.WSE: HEN | $21.40M | zł— | — |
| Brooks Laboratories LimitedNSEI: BROOKS | $21.35M | Rs70.13 | +27.97% |
| Human Metabolome Technologies, Inc.TSE: 6090 | $21.22M | ¥604.00 | -0.33% |
| atect corporationTSE: 4241 | $20.21M | ¥724.00 | +1.54% |
| SLS BIO Co., LtdKOSDAQ: A246250 | $19.85M | ₩— | — |
| Genolution Inc.KOSDAQ: A225220 | $19.41M | ₩1,444.00 | -1.70% |
| Promimic AB (publ)OM: PRO | $18.42M | Skr9.60 | -1.54% |
| OncoSil Medical LimitedASX: OSL | $17.93M | AU$0.70 | -11.39% |
Figures last refreshed Oct 11, 2026.